Company intelligence / Profile preview

Blue Cross Laboratories

Mumbai, Maharashtra, Indiabluecrosslabs.com ↗
Ownership
Private
Employees
~3400
Development stage
Other
01

Overview

Blue Cross Laboratories markets more than 160 pharmaceutical products, focusing on high-quality, affordable generics across key therapeutic areas with a global presence in over 15 countries and WHO-GMP, ISO 9001:2015 certified manufacturing[1][2][3].

Therapeutic areas
EndocrinologyRheumatologyInfectious DiseasesGastroenterologyDermatologyCardiovascular
Modalities
Small moleculeBiologic
Industry
Biotech
02

Drug pipeline

1 asset

Diclotal MR

Unknown

Beyond the preview

Go deeper on Blue Cross Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Blue Cross Laboratories.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call